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Abstract 
Morphologic and phenotypic changes occur during the 
maturation of megakaryocytes (MK) from the pluripotent 
stem cell to platelets. As the MK acquires organelles, it 
also acquires membrane glycoproteins and granule contents. 
Platelet membrane GP lib/Illa and platelet peroxidase are 
present from early stages of maturation to the final product 
of the megakaryocyte, the platelet, while Ia-like antigen 
appears to be expressed only during early stages of matura-
tion. The MK synthesizes increasing amounts of lysosomal 
enzymes, GP lb, and alpha granule proteins as it matures 
from the megakaryoblast stage to the mature cell. The 
platelet contains only vestiges of a protein synthetic 
apparatus; it therefore has acquired most of its contents, 
except for serotonin, during the maturation of the MK. 
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Introduction 
The maturation and differentiation of hematopoietic 
cells occurs in association with specific structural, func-
tional, and antigenic changes. Megakaryocytes mature in 
the following sequence: stem cell ➔ colony-forming-unit-
megakaryocyte (CFU-Meg) ➔ proliferative and non-
proliferative precursor ➔ promegakaryoblast ➔ 
megakaryoblast ➔ immature megakaryocyte ➔ maturing 
megakaryocyte ➔ mature megakaryocyte ➔ platelets 
(Table 1). It should be emphasized that this is a continuum 
of maturation and that overlap may occur between stages. 
As maturation proceeds, proliferative potential decreases. It 
is interesting to note that a "blast" cell in other cell lineages 
usually indicates a cell with proliferative potential whereas 
"megakaryoblast" indicates a nonproliferative cell. The 
stages of megakaryocyte maturation have previously been 
defined in terms of cytoplasmic maturation [27 , 58, 60], 
although more recently, Williams and Levine [84] have 
introduced nuclear configuration as another descriptive 
characteristic. Since it has been difficult to purify stem 
cells or CFU-Meg, the morphology of these cells has been 
only preliminarily described [77] . Promegakaryoblasts are 
difficult to identify on purely morphologic criteria. In 
mammals, immature megakaryocytes are small cells 
measuring 6 to 24 µm in the long axis [84], containing a 
large, round, indented, or lobed nucleus [52] with prom-
inent nucleoli, and having a high nuclear:cytoplasmic ratio. 
These cells contain few cytoplasmic organelles other than 
polyribosomes and mitochondria; a granules are infre-
quently seen [ 4, 5] . Lysosomal enzymes are present in this 
earliest recognizable cell of the megakaryocytic series, even 
before the formation of alpha granules and demarcation 
membranes are observed [4, 5] . Microperoxisomes are also 
formed early in megakaryocyte differentiation [IO]. Matur-
ing megakaryocytes are heterogeneous in size (14 to 30 
µm) and in the level of polyploidy (8 to 32N). They con-
tain a large protein synthetic apparatus and variable 
numbers of demarcation membranes and a granules. 
Mature megakaryocytes are approximately 20 to 50 µm in 
diameter [84], with a low nuclear:cytoplasmic ratio, and 
contain an extensive demarcation membrane system and a 
reduced protein synthetic apparatus. Studies of megakaryo-
cyte differentiation have reported changes in the phenotypic 
profile at various stages of maturation. 
This paper will describe what is currently known 
about megakaryocyte/platelet antigens during megakaryo-
cytopoiesis in vivo and in vitro, and examine the 
phenotypic characteristics of cells from patients with 
megakaryoblastic leukemia. 
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* Table 1. Characteristi cs of Maturational Stage s of Megakaryocytes 
Maturational Stage 




precursor (sAChE+ ) 
Prome gakaryo bla st 
*** Me ga karyobl as t 
Immature Me gakaryocyt e 
Maturing Megakaryocyt e 










20 - 50 
Demarcation 
Nuclear Morphology Membranes Granul es 
? ? ? 
? ? ? 
? ? ? 
round, nonsegme nted 
compact, lobed + (+) 
round , indented, or + + 
lobed 
horses hoe or mu lti- ++ ++ 
l obed 
compac t but multi- +++ +++ 
lobul at ed 
* Thi s t abl e i s deri ved from a se ri es of studi es in roden t s and huma ns and is a syn-
t hes i s of data from Pa ulu s (Bl ood 35 :298-3 11, 1970) , Ebbe and St ohl man (B l ood 26: 
20 - 35, 1965), Ode ll and Jackson (Blood 32:102-110 , 1968) , \~i ll iams and Levine -
(Br J Haema t ol 52 :173- 180 , 1982), Dupontet al. (B iol Ce ll 49: 137-143 , 1983) , 
Jac kso n (B l ood 42:413-421, 1973), Tranum-Jensen and Behnke Tsi ol Int Rep 1:445-452, 
1977 ) , Breton- Go ri us and Va i nchenker ( Sem Hema to l 23 : 43-67, 1986), and Spang rude 
et al . (Sc ience ~:58-62 , 1988) . -
** Sma ll, ace tyl cholines tera se -pos i t i ve ce ll. 
*** The definition s for megaka ryobl ast and i mmat ure megakaryocyte probabl y requ i re 
ad diti onal reso luti on. 
Megakacyocytes In Vivo 
Prior to the availability of immunocytochemical mark-
ers, histochemical stains were employed for the 
identification of megakaryocytes. Acetylcholinesterase 
staining has proved extremely useful in the identification of 
dog [39], cat [75, 76], rat [35, 75, 76], and murine 
[51 , 75 , 76] platelets and megakaryocytes, although it is not 
applicable for the identification of human megakaryocytes. 
Histochemical stains for acid phosphatase and aryl sulfatase 
identify primary lysosomes of rat and human megakaryo-
cytes [4, 5] . A peroxidase activity specific for the 
megakaryocyte/platelet lineage (PPO), localized to the 
endoplasmic reticulum and perinuclear envelope of the 
megakaryocyte and to the dense tubular system of the 
platelet, has been demonstrated [9] and applied to the 
identification of megakaryoblastic leukemia cells [11 , 12]. 
Breton-Gorius et al. [16] concluded that this PPO was the 
earliest known marker appearing in immature megakaryo-
cytes, since in bone marrow from a patient with 
megakaryoblastic leukemia, some promegakaryoblasts (the 
diploid precursors of megakaryoblasts) expressed both PPO 
and platelet membrane glycoproteins, while a few prome-
gakaryoblasts identified by PPO did not express these 
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glycoproteins. 
Recently, antibodies specific for platelet membrane 
glycoproteins have been employed in the identification of 
normal human megakaryocytes in vivo: both immature and 
mature megakaryocytes were labeled utilizing 
immunofluorescence techniques and antibodies directed 
against platelet glycoproteins [62, 63, 79]. A monoclonal 
antibody to the GP lib/Illa complex has been used to purify 
human megakaryocytes from sternal bone marrow [25] . 
Immunogold techniques at the ultrastructural level have 
localized platelet membrane glycoproteins to human [ 16] 
and murine [71] bone marrow megakaryocytes (Fig. 1). 
Levene et al. [42] have shown that monoclonal antibodies 
which immunoprecipitate platelet glycoprotein Ilb/Illa also 
recognize the committed progenitor colony-forming-unit-
megakaryocyte (CFU-Meg) (vide infra). Fraser et al. [29] 
have presented evidence that the human pluripotential 
hematopoietic stem cell expresses platelet lineage-specific 
markers. Jackson has demonstrated that small rat bone mar-
row cells expressing AChE activity also were labeled by 
fluorescent anti-platelet serum [36]. Immunofluorescence 
techniques also have localized platelet Factor 4 
[54,62,67, 81], ~-thromboglobulin [54], fibrinogen [62,81], 
thrombospondin [54] , FVIII:vWF [62, 63 , 81], fibronectin 
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Figure 1. (a) A mature mouse bone marrow megakaryocyte 
(MK) reacted with platelet antiserum followed by protein 
A-gold (size, 10 nm) probe. Label is present along the 
extent of the MK plasma membrane (arrows) and is absent 
from the plasma membrane of the neighboring cell. (b) A 
higher magnification of a cell from the same preparation, 
showing immunogold label along the plasma membrane and 
within an element of the demarcation membrane system 
(arrowhead). (Even though the demarcation membrane sys-
tem has been shown to be in continuity with the outside 
space, only rare immunogold particles were observed inside 
these elements because the large size of the particles inhi-
bited their entry into these channels). dms, demarcation 
membrane system; Ge, Golgi complex. 
[63], platelet-derived growth factor [81], and coagulation 
Factor V [57] to human bone marrow megakaryocytes. 
Immunoperoxidase techniques at the light microscope level 
have localized a granule membrane protein 140, thrombos-
pondin, FVIII:vWF, ~-thromboglobulin, platelet Factor 4, 
and fibrinogen in a granular distribution in human bone 
marrow megakaryocytes [3]. 
Flow cytometry is a potentially powerful tool for the 
study of megakaryocyte maturation, since it has the capabil-
ity of physically separating small subpopulations from a 
large number of cells and simultaneously measuring multi-
ple parameters. For example, flow cytometric techniques 
have been successfully used to study the development of 
erythroid cells and B-lymphocytes in human bone marrow 
[49, 50]. Loken et al. [50] were able to identify erythroid 
cells at various stages of maturation with three markers : 
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glycophorin A was expressed on mature erythrocytes but 
not on earliest precursor cells, the HLe-1 antigen was lost 
during maturation, and transferrin receptor was expressed at 
intermediate stages of erythroid development. Similar tech-
niques were used to define stages of B-lymphocyte matura-
tion based on cell surface antigen expression (49]. Although 
flow cytometric studies have been performed on 
megakaryocytes [7 , 23, 37, 47, 56, 74, 85], collectively these 
studies have been limited by poor discrimination between 
different populations of megakaryocytes, and/or histological 
identification restricted only to mature cells. Further use of 
this technology should enable the more precise 
identification of cells of this lineage at various stages of 
development. 
Megakaryocytes In Vitro 
Culture techniques are available which support the 
proliferation and differentiation of the progeny of CFU-
Meg, which are defined by their capacity to form 
megakaryocyte colonies in agar [55], methylcellulose [28], 
or plasma clot [78], in vitro. They have enabled the 
identification and study of immature megakaryocytes. At 
least two types of murine megakaryocyte colonies have 
been recognized in soft agar cultures [19, 44, 45 , 48, 82, 83]. 
One type is typically composed of 10-30 large megakaryo-
cytes which are mature in appearance ("big cell" type) . 
The other ("heterogeneous" type) is composed of more cells 
(often greater than 100), some of which are small and 
immature as evaluated in part by staining for acetylcho-
linesterase, a specific marker for murine megakaryocytes. 
Recently, murine megakaryocytes from big cell and 
heterogeneous colonies grown in soft agar culture have 
been identified and characterized by labeling for 
megakaryocyte/platelet antigens (70, 71]. The use of 
specific markers on megakaryocytes grown in soft agar cul-
tures allows one to examine patterns of protein expression 
in megakaryocytes at early time points in culture and par-
ticularly, to study the small immature cells which partially 
constitute the heterogeneous megakaryocyte colonies. The 
investigation of murine heterogeneous colonies is of partic-
ular interest, since it is believed that they are composed 
solely of megakaryocytes and their precursors [ 44-46] and 
offer the first opportunity to study by morphological pro-
cedures the development of cells of the megakaryocyte 
lineage starting with diploid (2N) precursors. For example, 
a recent study utilizing acetylcholinesterase histochemistry 
at the fine-structural level on murine colonies has allowed 
the identification of small immature cells as megakaryo-
cytes [71] (Fig. 2). 
The use of markers in in vitro systems has permitted 
limited studies of the transitional maturation stages between 
CFU-Meg and megakaryocytes. For example, it has been 
demonstrated in the mouse that the small 
acetylcholinesterase-positive cell represents an intermediary 
stage between the CFU-Meg and the megakaryocyte 
[51, 52, 77], and small cells expressing platelet glycopro-
teins or cytoplasmic factors have been described in humans 
in vitro, in plasma clot cultures [22, 53, 79], and in murine 
megakaryocyte colonies grown in soft agar cultures [43, 71] 
(Fig. 3). In a study of human megakaryocytes grown in 
methylcellulose culture, at days 4 and 5 there was a number 
of cells 8-10 µm in diameter which expressed the GP 
IIb/lIIa complex and a smaller number which labeled for 
GP lb and the cytoplasmic proteins vWF, PF4, and throm-
bospondin [80]. By day 7 of culture, 75% of cells were 
double-labeled with antibodies to membrane and cyto-
plasmic constituents, and the number of labeled cells 
Paula E. Stenherg 
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Figure 2. An immature mouse megakaryocyte from a 7-
day heterogeneous colony reacted for acetylcholinesterase. 
Reaction product is confined to the perinuclear cistema (pc) 
and the rough endoplasmic reticulum (rer). N, nucleus. 
increased significantly after 7 days. These investigators 
concluded that all platelet proteins which they examined are 
expressed by promegakaryoblasts, but that GP lib and GP 
IIIa are present earlier in differentiation than the other pro-
teins [80]. 
Antigenic Similarities and Differences between 
Megakaryocytes and Platelets 
Numerous studies have been performed to examine the 
expression of antigens at various times during human or 
murine megakaryocyte development. Changes in antigenic 
profiles may be attributed to a) acquisition of new 
antigens, b) exposure of cryptic antigens, or c) loss of 
antigenic sites. Most of these studies have been performed 
using immunofluorescence techniques or ultrastructural 
immunogold techniques; polyclonal antibodies to GP 
IIb/IIIa, or monoclonal antibodies to various epitopes of GP 
IIb, GP IIIa, or the complex GP Ilb/Illa have been used 
most frequently. 
The expression of GP Ilb/IIIa throughout the 
megakaryocyte/platelet lineage is somewhat controversial 
(Table 2). Polyclonal antibodies to GP IIb/IIIa or mono-
clonal antibodies to epitopes of these glycoproteins have 
been used to detect this antigen on stem cells [6, 29], 
CFU-Meg [6, 42], immature megakaryocytes 
[3, 6, 14, 25, 29, 31, 41, 42, 62, 63, 73, 81), mature megakaryo-
cytes [3, 6, 14, 25, 29, 31, 34, 41, 42, 62, 63, 73, 81], and plate-
lets [6, 14, 25, 29, 31, 34, 42, 63, 73]. Although GP Ilb/IIIa 
has been reported to be expressed on human pluripotent 
stem cells and CFU-Meg using absorbed heteroantisera [6], 
this complex was visualized by immunofluorescence only 
on day 4 or 5 in cultures of human CFU-Meg [80) . These 
discrepant results may be due to technical differences 
Figure 3. (a) An immature mouse megakaryocyte from a 
7-day heterogeneous colony reacted for platelet antiserum 
followed by protein A-gold (size, 10 nm) probe. (b) At 
higher magnification of this cell , immunogold label is 
apparent along the extent of the plasma membrane (arrows). 
dms, demarcation membrane system; N, nucleus. 
between the spleen colony inhibition assay and 
immunofluorescence techniques used in cultures of CFU-
Meg. Interestingly, an immunocytochemical study of 
murine megakaryocytes in vitro reported that all cells in 
megakaryocyte colonies grown in soft agar culture, regard-
less of time in culture or extent of differentiation, exhibited 
a similar density of immunogold label along the plasma 
membrane with platelet antiserum or anti-GP Illa serum 
[71). It should be noted that GP Illa has been reported on 
the surfaces of endothelial cells and some osteoclasts [3] . 
Therefore, several markers should be used simultaneously 
to determine cell lineage specificity. 
Studies which have compared the distributions of GP 
lb and GP Ilb/IIIa on differentiating megakaryocytes have 
concluded that GP lb is expressed early in megakaryocyte 
maturation, but that there is a greater variability in expres-
sion of GP lb on platelet and mature megakaryocyte plasma 
membranes than there is for GP Ilb/llla [14, 34, 63, 81) 
(Table 3). Hyde et al. [34) reported that only 24% of 
megakaryocytes reacted with anti-GP lb antibodies whereas 
other investigators have reported that all megakaryocytes 
and their precursors stained with monoclonal antibodies to 
GP lb [14]. These conflicting results may be due to 
technical problems in detecting label on small mononuclear 
cells which are the megakaryocyte precursors. Since there 
are fewer antigenic sites on megakaryocyte plasma mem-
branes for GP lb than there are for GP lib/Illa [14), it is 
important that other markers be utilized in conjunction with 
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Table 2. 
Antibody Spec ifi city 
o. -IIIa(P) Illa 
o. -Ilb(P) Ilb 
o. -IIIa(P) II Ia 
PBM6.4(M) I lb/Illa 
Jl5(M) I lb/Illa 
Jl5(M) I lb/Illa 
a. -IIb/IIIa(P) I lb/Illa 
a. -HuPl-ml (r~) Ilb & Illa 
PC-l(M) I lb/I I Ia 
PC-3(M) 
PC-4(M) 
APS(P) PLT MB 
Jl5(M) I lb/Illa 
A5 .1 5(M) I lb/Illa 
Allbs(P) Ilb 
Alllas(P ) Illa 
APS(P) PLT MB 
TPBO(M) I lb/Illa 
PLT-2(M) 
10E5(M) llb/IIIa 
o. -Illa(P) Illa 
Tab(M) Ilb 
TlO(M) I lb/Illa 
ND=not described 
P=polyclona l antibody 
M=monoclona l antibody 
MK=megakaryocyte 
PLT MB=p l atelet membrane 
H=human 
f'i=mouse 
Expression of GP IIb/ III a Du ring ~egakaryocyte Maturation 
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+ + rm H IF 62 
+ + + H IF 63 
+ + + 
+ + + H IF 25 
+ + + H IF,IG 14 
+ + ND H IF, IG 81 
+ + + H IF,IG,EIP 31 
+ + + H IF 73 
I 
+ + + H IF,C -MC, 42 
ELISA 
+ + + M IF,SCIA 6 
+ + + 
+ + + 
I 
ND ND + H IF,C -DCA 29 
ND ND + 
+ + + 
+ + ND H FACS,IAP 41 
ND + + H lF,IG 34 
+ + rm H LIP 3 
Detection Method: 
IF=Immunofluorescence 
l G= lmmunogo ld 
EIP=Electron microscope immunoperoxidase techniques 
LIP=Light microscope immunoperoxidase techniques 
C1 -MC=Complement-mediated cyto lys i s 
ELISA=Enzyme-linked immuno sorbent assay 
SC IA= Spl een co lony inhibition assay 
C
1
-DCA=Complement-dependent cytotoxic assay 
against CFU-mix 
lAP=lmmunoalkaline phosphatase t echnique s 
FACS=Fluorescence-activated cell cytometry 
antibodies to GP lb for diagnostic purposes (vide infra). mature human megakaryocytes, but not on immature 
megakaryocytes or platelets. In contrast, Koik:e et al. [41] 
reported the presence of HLA-DR antigen on immature 
human megakaryocytes but not on mature megakaryocytes; 
platelets were not examined. Bodger et al . [8] noted the 
presence of HLA-DR or Ia-like antigens on human pluripo-
tent stem cells and CFU-Meg, although further stages of 
Several groups of investigators have reported changes 
in the expression of Ia-like antigens as megakaryocytes 
develop from the immature stage to the platelet 
[8,25, 41 ,62,63, 73,81] (Table 3). Damiani et al. [25] 
reported the expression of HLA-DR or Ia-like antigen using 
the monoclonal antibodies DR and DCl on the surface of 
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ND=not described, P=polyclonal antibody, M=monoclonal antibody, MK=megakaryocyte, H=human, 
MTmouse, IF=Immunofluorescence, IG=Immunogold, ELISA=Enzyme-linked immunosorbent assay, 
C -MC=Complement-mediated cytolysis, SCIA=Spleen colony inhibition assay, FACS=Fluorescence 
activated flow cytometry, C -RA=Complement receptor assay, IFe=Immunoferritin 
maturation were not studied. Another study reported the 
presence of Ia-like antigen on a majority of mouse platelets, 
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on 16% of mouse megakaryocytes, and on 0% of mouse 
megakaryocyte precursors [62], while Thurlow et al. [73] 
Phenotypic Changes in Megakaryocytes and Platelets 
reported human platelets and megakaryocytes to be nega-
tive for Ia-like antigen. A study of human megakaryocytes 
grown in plasma clot cultures reported that HLA-DR was 
expressed in promegakaryoblasts but not on mature 
megakaryocytes or platelets [81). Therefore, the majority 
of studies have reported the presence of la-like antigen on 
early megakaryocytes and the absence of this antigen on 
megakaryocytes at later stages of maturation. Clearly, 
more data will be required to clarify the distribution of 
these antigens on differentiating megakaryocytes. 
In addition, an early study reported that 30% of mouse 
megakaryocytes expressed CR1 (immunoadherence (C4b-C3b) receptor) together with a proportion of blood platelets, 
suggesting that this receptor may be acquired at a late stage 
of development [62]; human megakaryocytes did not 
express this receptor, but did express the Fe-receptor 
[62,64]. Koike et al. [41] reported that antigens identified 
by monoclonal antibodies MYIO and MY9 (which are used 
to identify myeloid cells) were present on immature human 
megakaryocytes but not on mature megakaryocytes. The 
2H antigens of the ABO blood group system were reported 
to be heterogeneously expressed in human CFlJ-Meg using 
indirect immunofluorescence techniques [26] . 
It would be interesting to determine whether the 
CFU-Meg compartment is phenotypically heterogeneous. 
Enriched samples of murine CFlJ-Meg, which can be 
obtained with a one-step procedure [59), provide the basis 
for a useful system with which to study this question. Jen-
kins et al. [38] have shown that megakaryocytes derived 
from human CFU-Meg synthesize GP IIb and Illa, and 
Levene et al. [ 42] demonstrated expression of the GP 
IIb/IIIa complex on human CFU-Meg using a panel of 
monoclonal antibodies in conjunction with 
immunofluorescence, an enzyme-linked immunosorbent 
assay, and complement-mediated cytolysis. Monoclonal 
antibodies which bind to subpopulations of bone marrow 
stem cells may be useful for stem cell purification [65]. 
A substance which platelets appear to acquire in their 
dense granules after they circulate in blood is serotonin (5-
hydroxytryptamine); dense granules have generally not been 
reported in megakaryocyte cytoplasm [61] . However, the 
precursors of these amine storage organelles in rat 
megakaryocytes were identified using the uranaffin reaction 
for adenine nucleotides [24], and this uranaffin reaction and 
mepacrine labeling have been reported to identify dense 
bodies in maturing human megakaryocytes [30]. In addi-
tion, serotonin uptake has been shown to be a marker for 
the identification of immature megakaryocytes [69] and 
megakaryocytes maturing in vitro from CFU-Meg [18]. 
Phenotypic Profile of Cells from Patients 
with Megakaryoblastic.: Leukemia 
Cases of megakaryoblastic leukemia are becoming 
more commonly recognized [1, 12, 33, 40, 41, 64, 66, 68, 72]. 
In a morphologic study of megakaryoblastic leukemia, 
Breton-Gorius described these cells as undifferentiated or 
lymphoid-appearing blasts which did not yet contain 
granules or demarcation membranes [12]. With the 
discovery of PPO (platelet peroxidase) as a specific marker 
for cells of the megakaryocyte-platelet lineage, Breton-
Gorius and her co-workers established its presence in the 
rough endoplasmic reticulum and nuclear envelope of cells 
from patients with megakaryoblastic leukemia [12, 15]. 
Even though immunocytochemical markers to GP IIb/IIIa 
and GP Ib have been utilized successfully to identify some 
immature cells in these cases as megakaryocytic 
[33, 68, 72], and PPO has been considered a very sensitive 
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marker of human megakaryocytes in vivo and in vitro 
[16, 40, 72, 78, 79], it is unclear which appears earlier in 
maturation, since the expression of PPO has not been stu-
died yet in stem cells. 
Histochemical studies of cases of megakaryoblastic 
leukemia have demonstrated that cells from some patients 
are a-naphthyl acetate esterase-positive [15, 40], a-naphthyl 
butyrate esterase-negative [15, 33, 40], acid phosphatase-
positive [33, 40], periodic acid-Schiff-positive [33], and 
chloroacetate esterase-negative [33], a pattern which is con-
sistent with the enzymatic content of normal megakaryo-
cytes [2, 3]. However, although these markers are useful 
for a differential diagnosis, they are not specific for the 
megakaryocyte/platelet lineage. 
Some investigators have suggested that the 
myelofibrosis present in many cases of megakaryoblastic 
leukemia results from the abnormal presence of intracyto-
plasmic megakaryocyte components in the bone marrow 
interstitial space, leading to changes in the rate of collagen 
secretion and inhibition of collagenase by megakaryocyte-
derived growth factor and platelet Factor 4, respectively 
[1, 13, 15, 20, 21]. An immunohistochemical study compar-
ing 4 cases of acute myelofibrosis with 3 cases of acute 
megakaryoblastic leukemia concluded that the blast cells of 
acute myelofibrosis are capable of differentiating along 
various cell lines and are not limited to megakaryocyte 
differentiation, suggesting that myelofibrosis and 
megakaryoblastic leukemia are not identical [32]. Recently, 
a study by Breton-Gorius et al. [17] has emphasized the 
need for the simultaneous use of several lineage restricted 
markers in the diagnosis of leukemia, since they detected 
PPO activity in most cases of early erythroid leukemia, and 
carbonic anhydrase and ferritin (erythroid markers) in some 
leukemic platelets and micromegakaryocytes . 
Based upon data obtained from studies of normal 
megakaryocytes and megakaryocytes from leukemic 
patients, a scheme for the appearance of various morpholo-
gic compartments and antigens during the maturation of 
this cell lineage is proposed (Table 4). 
Summary 
As megakaryocytes mature and differentiate, they 
acquire increasing amounts of certain organelles and con-
tain decreasing amounts of others. Immature megakaryo-
cytes contain abundant rough endoplasmic reticulum and 
Golgi complex, but few granules and demarcation mem-
branes. In contrast, mature megakaryocytes contain 
decreasing amounts of rough endoplasmic reticulum and 
Golgi complex, and increasing amounts of granules and 
demarcation membranes. 
Similarly, megakaryocytes lose and acquire various 
markers throughout their maturational stages. At one end 
of the megakaryocyte maturational spectrum is la-like 
antigen, which appears to be present only in immature 
megakaryocytes. At the other end of the spectrum is sero-
tonin, which is generally observed only in platelets. GP 
Ilb/IIIa and platelet peroxidase are expressed extremely 
early in differentiation. GP lb, lysosomal enzymes, and a 
granule components appear somewhat later in maturation 
than GP Ilb/Illa and platelet peroxidase. Recent studies 
point to the necessity of using several different markers 
simultaneously to accurately diagnose leukemia. The 
purification of pluripotent stem cells and CFU-Meg will 
facilitate further studies on the phenotypic profile(s) of 
megakaryocytes at the earliest stages of development. 
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Table 4. Appearance of Organelles and Markers During the Maturation and 
Differentiation of the Megakaryocyte/Platelet Lineage* 
Pluripotent CFU- Meg Promegakaryoblast/ Immature Mature Platelet 
Stem Cell _ _ _ Megakaryoblast MK** MK 
ORGANELLES 
Endoplasmic Reticulum 














HLA-DR (Ia-like antigen) ---------------
GP !lb/Illa 
GP lb 
FVII IR :Ag/vWF 
c(- naphthyl acetate 
esterase 
Acid Phosphatase 




* Modified from Koike (Blood 64:683, 1984) and Koike et al . (Blood 69:957, 1987). This 
table is based, in part, onaata obtained from leukemic megakaryocyte precursors and it 
cannot be excluded that normal maturation is slightly different. 
** MK=megakaryocyte 
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